Literature DB >> 21235869

Arrhythmogenic right ventricular cardiomyopathy a still underrecognized clinic entity.

G Thiene1, C Basso, G Danieli, A Rampazzo, D Corrado, A Nava.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy is a new morbid entity that was discovered thanks to the study of sudden death in the young. This heart muscle disease is characterized by myocardial atrophy, mostly of the right ventricle, with massive fibro-fatty infiltration, accounting for ventricular electrical instability at risk of severe arrhythmias and even cardiac arrest. The disease was found to be the major cause of sudden death in young people and athletes in the Veneto Region, Italy. A familial occurrence with autosomal dominant transmission was then discovered, and the prevalence was estimated to be higher than 1 in 5000. The disease is genetically heterogeneous: Linkage analysis, carried out in a large family with recurrence of sudden deaths, led to map the gene to chromosome 14q23-q24. Linkage analysis in a second family allowed mapping of another gene to chromosome 1q42-q43. Clinical diagnosis can be achieved through electrocardiography, echocardiography, angiocardiography, magnetic resonance imaging, and endomyocardial biopsy. Diagnostic criteria have been put forward by a committee of the International Society and Federation of Cardiology. The disease was recently included among the cardiomyopathies in the revised World Health Organization (WHO) classification. Study of the natural history allowed us to distinguish (a) a covert phase in apparently normal subjects who have a risk of abrupt electrical instability and sudden death, (b) an overt arrhythmic phase with palpitations and impending cardiac arrest, (c) congestive heart failure with pump depression, sometimes so severe as to require heart transplantation. Both the etiology and pathogenesis of the disease are unknown. In particular, the mechanisms leading to progressive loss of myocardium and fibro-fatty replacement are still speculative. Apoptosis in the right ventricle occurring not only in infancy, as in the normal heart, but also in childhood and adulthood might account for the progressive disappearance of myocardial tissue. (Trends Cardiovasc Med 1997;7:84-90). © 1997, Elsevier Science Inc.
Copyright © 1997 Elsevier Science Inc. All rights reserved.

Entities:  

Year:  1997        PMID: 21235869     DOI: 10.1016/S1050-1738(97)00011-X

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  12 in total

1.  The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.

Authors:  D Li; F Ahmad; M J Gardner; D Weilbaecher; R Hill; A Karibe; O Gonzalez; T Tapscott; G P Sharratt; L L Bachinski; R Roberts
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Sudden cardiac death due to arrhythmogenic right ventricular cardiomyopathy and cystic tumor of the AV node.

Authors:  John Cavanaugh; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2013-04-06       Impact factor: 2.007

3.  Is cardiac MRI an effective test for arrhythmogenic right ventricular cardiomyopathy diagnosis?

Authors:  Santhi Chellamuthu; Alyson M Smith; Steven M Thomas; Catherine Hill; Peter W G Brown; Abdallah Al-Mohammad
Journal:  World J Cardiol       Date:  2014-07-26

4.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

Authors:  Kathy A Hodgkinson; Patrick S Parfrey; Anne S Bassett; Christine Kupprion; Jörg Drenckhahn; Mark W Norman; Ludwig Thierfelder; Susan N Stuckless; Elizabeth L Dicks; William J McKenna; Sean P Connors
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

Review 5.  Insect ryanodine receptors: molecular targets for novel pest control chemicals.

Authors:  David B Sattelle; Daniel Cordova; Timothy R Cheek
Journal:  Invert Neurosci       Date:  2008-08-12

6.  Arrhythmogenic Right Ventricular Dysplasia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10

7.  Is arrhythmogenic right ventricular cardiomyopathy a paediatric problem too?

Authors:  P Turrini; C Basso; L Daliento; A Nava; G Thiene
Journal:  Images Paediatr Cardiol       Date:  2001-01

8.  Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Revathi Rajkumar; John C Sembrat; Barbara McDonough; Christine E Seidman; Ferhaan Ahmad
Journal:  BMC Med Genet       Date:  2012-03-29       Impact factor: 2.103

9.  Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes.

Authors:  Luzuko O Matolweni; Soraya Bardien; George Rebello; Ekow Oppon; Miroslav Munclinger; Rajkumar Ramesar; Hugh Watkins; Bongani M Mayosi
Journal:  BMC Med Genet       Date:  2006-03-28       Impact factor: 2.103

10.  Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review.

Authors:  Jorge Romero; Eliany Mejia-Lopez; Carlos Manrique; Richard Lucariello
Journal:  Clin Med Insights Cardiol       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.